Comparison results
| Results: Differences General | ✘Erythroplasia of Keira | ✘Chronic monocytic leukemia | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 58% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 92% | ||||||||||
| bowen's disease | 54% | — | ||||||||||
| lowered | — | 62% | ||||||||||
| leukocyturia | 53% | — | ||||||||||
| acute leukemia | — | 61% | ||||||||||
| proteinuria | 47% | — | ||||||||||
| monocytosis | — | 57% | ||||||||||
| cancer of the mucous membranes of the mouth | 46% | — | ||||||||||
| professional cancer | — | 48% | ||||||||||
| epithelioma | 42% | — | ||||||||||
| thrombocytopenia | — | 36% | ||||||||||
| penile cancer | 37% | — | ||||||||||
| waldenstrom 's macroglobulinemia | — | 34% | ||||||||||
| skin cancer | 36% | — | ||||||||||
| erythrocytic anemia | — | 34% | ||||||||||
| genital neoplasms | 36% | — | ||||||||||
| chronic leukemia | — | 33% | ||||||||||
| squamous cell carcinoma | 34% | — | ||||||||||
| chronic myeloid leukemia | — | 31% | ||||||||||
| operations in the oral cavity | 31% | — | ||||||||||
| increased gamma globulins | — | 29% | ||||||||||
| hyperemia of genitals | 28% | — | ||||||||||
| leukemia | — | 26% | ||||||||||
| precancer | 27% | — | ||||||||||
| hemorrhagic syndrome | — | 26% | ||||||||||
| basal | 27% | — | ||||||||||
| subacute condition | — | 26% | ||||||||||
| carcinoid | 27% | — | ||||||||||
| enlargement of the liver and spleen | — | 23% | ||||||||||
| skin problems | 26% | — | ||||||||||
| hepatosplenomegaly | — | 23% | ||||||||||
| inflammation of the glans penis | 26% | — | ||||||||||
| anemia | — | 22% | ||||||||||
| oncology | 26% | — | ||||||||||
| very correct | — | 22% | ||||||||||
| history of surgery | 25% | — | ||||||||||
| enlargement of the spleen | — | 22% | ||||||||||
| balanoposthitis in boys | 23% | — | ||||||||||
| chronic anemia | — | 22% | ||||||||||
| clear boundaries | 22% | — | ||||||||||
| increased ESR | — | 22% | ||||||||||
| lot of operations in small things | 21% | — | ||||||||||
| blood diseases | 12% | 33% | ||||||||||
| lymphosarcoma | 21% | — | ||||||||||
| leukocytosis | — | 20% | ||||||||||
| a lot of medicines | 20% | — | ||||||||||
| increased | 11% | 31% | ||||||||||
| dry | 19% | — | ||||||||||
| enlarged liver | — | 20% | ||||||||||
| at night 2 4 times | 18% | — | ||||||||||
| tuberculosis | — | 20% | ||||||||||
| stomatitis | 18% | — | ||||||||||
| high temperature | — | 18% | ||||||||||
| skin overgrowth | 17% | — | ||||||||||
| feeling of heat | — | 18% | ||||||||||
| drug disease | 17% | — | ||||||||||
| childhood diseases | — | 17% | ||||||||||
| hyperpigmentation | 17% | — | ||||||||||
| metastases | 15% | 23% | ||||||||||
| hair loss | 17% | — | ||||||||||
| more often in old age | 17% | 23% | ||||||||||
| dermatitis | 15% | — | ||||||||||
| hyperchromia | 100% | 100% | ||||||||||
| reddening of the skin | 15% | — | ||||||||||
| lymph node damage | 15% | — | ||||||||||
| pneumonia | 14% | — | ||||||||||
| radiation therapy | 14% | — | ||||||||||
| radiation damage | 14% | — | ||||||||||
| suspicion | 14% | — | ||||||||||
| gradual deterioration of the condition | 14% | — | ||||||||||
| bleeding | 13% | — | ||||||||||
| necrosis | 13% | — | ||||||||||
| nausea | 13% | — | ||||||||||
| consequences of taking medications | 12% | — | ||||||||||
| patient's condition | 11% | — | ||||||||||
| cancer | 28% | 21% | ||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
